Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
varlitinib (ASLAN001)
i
Other names:
ASLAN001, ARRY 334543, ARRY-543, ARRY-334543, ASLAN-001, ASLAN 001, AR 00334543, ARRY334543, ARRY543, ARRY 543, SPS-4370, QBT-01, QBT01
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(6)
News
Trials
Company:
ASLAN Pharma, Blade Entertaintment, Pfizer
Drug class:
EGFR inhibitor, HER2 inhibitor, HER4 inhibitor
Related drugs:
‹
cetuximab (347)
osimertinib (301)
erlotinib (235)
afatinib (227)
gefitinib (194)
panitumumab (123)
lapatinib (107)
neratinib (102)
pyrotinib (79)
brigatinib (50)
icotinib (45)
aumolertinib (39)
amivantamab-vmjw (25)
firmonertinib (14)
mobocertinib (12)
lazertinib (12)
BGB-283 (12)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
nimotuzumab (6)
BLU-945 (6)
BBT-176 (5)
CL-387785 (5)
GB263T (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BI-4020 (4)
tomuzotuximab (4)
JIN-A02 (4)
MET306 (4)
EGF816 (4)
BDTX-1535 (4)
AFM24 (3)
BLU-701 (3)
GC-1118A (3)
necitumumab (3)
befotertinib (3)
sunvozertinib (3)
zorifertinib (3)
BCA101 (3)
S95026 (3)
ASP8273 (3)
MCLA-129 (3)
SZMD4 (3)
ACE2016 (2)
BI-732 (2)
BLU-451 (2)
Bay846 (2)
ERAS-801 (2)
OBX02-011 (2)
olmutinib (2)
QL1203 (2)
CLN-081 (2)
14aj (1)
αEGFR (1)
ABP 494 (cetuximab biosimilar) (1)
APL-103 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
sevabertinib (1)
KKI04 (1)
PH001 (1)
rilertinib (1)
TAS3351 (1)
TRX-221 (1)
WSD0922 (1)
JMT101 (1)
RT1978 (1)
HMPL-813 (1)
SI-B001 (1)
ASK120067 (1)
HLX07 (1)
Hemay022 (1)
KD019 (1)
ABT-101 (0)
AC480 (0)
AG1478 (0)
BBT-207 (0)
BC3448 (0)
BMS690514 (0)
BNA035 (0)
CM93 (0)
CUDC-101 (0)
EGF-PTI (0)
DF9001 (0)
EGFR (0)
STI-001 (cetuximab biosimilar) (0)
FHND9041 (0)
HS-10375 (0)
antroquinonol (0)
zalutumumab (0)
IAE0972 (0)
IBI-334 (0)
JANX008 (0)
JNJ-26483327 (0)
JS111 (0)
asandeutertinib (0)
MM-151 (0)
MP412 (0)
MTX-211 (0)
PF-08046052 (0)
PM1080 (0)
QLH11811 (0)
rindopepimut (0)
SR13668 (0)
SYN004 (0)
Sym013 (0)
TAK-186 (0)
TAK-285 (0)
TAS-121 (0)
TAVO412 (0)
TQ-B3456 (0)
TQB3804 (0)
U3-1565 (0)
Undisclosed EGFR inhibitor (0)
XZP-5809 (0)
simotinib (0)
ZN-e4 (0)
AST1306 (0)
SY101 (0)
Ami-LC (0)
PLB1004 (0)
EMB-01 (0)
cetuximab biosimilar (0)
cipatinib (0)
ABT-806 (0)
MEHD7945A (0)
RO5083945 (0)
TL007 (0)
EMD 72000 (0)
PF-06747775 (0)
JNJ-64041757 (0)
KBP-5209 (0)
SKLB-1028 (0)
AZD8931 (0)
trastuzumab (407)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
inetetamab (6)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
AST-301 (2)
CT-0508 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
IAH0968 (1)
MP0274 (1)
Paletan (pertuzumab biosimilar) (1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
ABL105 (1)
RG6596 (1)
IMM2902 (1)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
CAM-H2 (0)
CAT-179 (0)
DA 3111 (trastuzumab biosimilar) (0)
EG1206A (pertuzumab biosimilar) (0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
Faceptor (trastuzumab biosimilar) (0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
SYSA1901 (pertuzumab biosimilar) (0)
TAC100-HER2 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
dHER2+AS15 (0)
IBI315 (0)
RG6194 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
cetuximab (347)
osimertinib (301)
erlotinib (235)
afatinib (227)
gefitinib (194)
panitumumab (123)
lapatinib (107)
neratinib (102)
pyrotinib (79)
brigatinib (50)
icotinib (45)
aumolertinib (39)
amivantamab-vmjw (25)
firmonertinib (14)
mobocertinib (12)
lazertinib (12)
BGB-283 (12)
tarloxotinib bromide (7)
WZ4002 (7)
CH7233163 (6)
H002 (6)
nimotuzumab (6)
BLU-945 (6)
BBT-176 (5)
CL-387785 (5)
GB263T (5)
rociletinib (5)
BDTX-189 (5)
AEE788 (4)
BI-4020 (4)
tomuzotuximab (4)
JIN-A02 (4)
MET306 (4)
EGF816 (4)
BDTX-1535 (4)
AFM24 (3)
BLU-701 (3)
GC-1118A (3)
necitumumab (3)
befotertinib (3)
sunvozertinib (3)
zorifertinib (3)
BCA101 (3)
S95026 (3)
ASP8273 (3)
MCLA-129 (3)
SZMD4 (3)
ACE2016 (2)
BI-732 (2)
BLU-451 (2)
Bay846 (2)
ERAS-801 (2)
OBX02-011 (2)
olmutinib (2)
QL1203 (2)
CLN-081 (2)
14aj (1)
αEGFR (1)
ABP 494 (cetuximab biosimilar) (1)
APL-103 (1)
BPI-15086 (1)
BPI-361175 (1)
Compound 6a (1)
abivertinib (1)
sevabertinib (1)
KKI04 (1)
PH001 (1)
rilertinib (1)
TAS3351 (1)
TRX-221 (1)
WSD0922 (1)
JMT101 (1)
RT1978 (1)
HMPL-813 (1)
SI-B001 (1)
ASK120067 (1)
HLX07 (1)
Hemay022 (1)
KD019 (1)
ABT-101 (0)
AC480 (0)
AG1478 (0)
BBT-207 (0)
BC3448 (0)
BMS690514 (0)
BNA035 (0)
CM93 (0)
CUDC-101 (0)
EGF-PTI (0)
DF9001 (0)
EGFR (0)
STI-001 (cetuximab biosimilar) (0)
FHND9041 (0)
HS-10375 (0)
antroquinonol (0)
zalutumumab (0)
IAE0972 (0)
IBI-334 (0)
JANX008 (0)
JNJ-26483327 (0)
JS111 (0)
asandeutertinib (0)
MM-151 (0)
MP412 (0)
MTX-211 (0)
PF-08046052 (0)
PM1080 (0)
QLH11811 (0)
rindopepimut (0)
SR13668 (0)
SYN004 (0)
Sym013 (0)
TAK-186 (0)
TAK-285 (0)
TAS-121 (0)
TAVO412 (0)
TQ-B3456 (0)
TQB3804 (0)
U3-1565 (0)
Undisclosed EGFR inhibitor (0)
XZP-5809 (0)
simotinib (0)
ZN-e4 (0)
AST1306 (0)
SY101 (0)
Ami-LC (0)
PLB1004 (0)
EMB-01 (0)
cetuximab biosimilar (0)
cipatinib (0)
ABT-806 (0)
MEHD7945A (0)
RO5083945 (0)
TL007 (0)
EMD 72000 (0)
PF-06747775 (0)
JNJ-64041757 (0)
KBP-5209 (0)
SKLB-1028 (0)
AZD8931 (0)
trastuzumab (407)
tucatinib (39)
trastuzumab-pkrb (24)
margetuximab-cmkb (18)
poziotinib (17)
zenocutuzumab-zbco (16)
KN026 (14)
trastuzumab-dttb (11)
zanidatamab-hrii (11)
trastuzumab-strf (9)
trastuzumab-anns (9)
trastuzumab-dkst (9)
trastuzumab-qyyp (9)
LZM-005 (8)
PRS-343 (8)
D3L-001 (7)
inetetamab (6)
MT-5111 (4)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
GNP101 (3)
pertuzumab/trastuzumab/hyaluronidase-zzxf (3)
AST-301 (2)
CT-0508 (2)
DF1001 (2)
ER121 (2)
Her-VAXX (2)
trastuzumab/hyaluronidase-oysk (2)
JBJ-08–178–01 (2)
VIR-5818 (2)
BDC-1001 (2)
ACE1702 (1)
Hercease (trastuzumab biosimilar) (1)
BAY2701439 (1)
DZD1516 (1)
GCC2003 (1)
HERtiCAD (trastuzumab biosimilar) (1)
Hervelous (trastuzumab biosimilar) (1)
EG12014 (trastuzumab biosimilar) (1)
IAH0968 (1)
MP0274 (1)
(1)
SAR443216 (1)
TX05 (trastuzumab biosimilar) (1)
VRN101099 (1)
ABL105 (1)
RG6596 (1)
IMM2902 (1)
ADG138 (0)
ALT02 (trastuzumab biosimilar) (0)
trastuzumab biosimilar (AP062) (0)
B-Vaxx (0)
BAT1006 (0)
BAY2701438 (0)
CAM-H2 (0)
CAT-179 (0)
DA 3111 (trastuzumab biosimilar) (0)
(0)
ELVN-002 (0)
ES2B-C001 (0)
ETBX-021 (0)
(0)
GB235 (0)
HER-2/neu peptide vaccine (0)
HER2 t-haNK (0)
HF158K1 (0)
Hervycta (trastuzumab biosimilar) (0)
ISB 1302 (0)
diznalimgene lisbac (0)
MBS301 (0)
MM 111 (0)
MVA-BN-HER2 (0)
NVL-330 (0)
NeuCeptin (trastuzumab biosimilar) (0)
nelipepimut-S (0)
lapuleucel-T (0)
OS47701 (0)
pertuzumab-dpzb (0)
QP34563457 (0)
ertumaxomab (0)
trastuzumab biosimilar (SIBP-01) (0)
SPH5030 (0)
SSGJ-705 (0)
(0)
TAC100-HER2 (0)
TAS0728 (0)
TPIV100 (0)
TQB2930 (0)
glycooptimized trastuzumab-GEX (0)
TrastuRel (trastuzumab biosimilar) (0)
Undisclosed HER2Bi-armed ATC (0)
VM 206 (0)
YH42946 (0)
dHER2+AS15 (0)
IBI315 (0)
RG6194 (0)
trastuzumab biosimilar (0)
trastuzumab biosimilar (0)
›
Associations
(6)
News
Trials
VERI cancer hierarchy
Reset Filters
HER-2 overexpression
Gastric Cancer
HER-2 overexpression
Gastric Cancer
ASLAN001
Sensitive: C2 – Inclusion Criteria
ASLAN001
Sensitive
:
C2
ASLAN001
Sensitive: C2 – Inclusion Criteria
ASLAN001
Sensitive
:
C2
HER-2 positive
HER2 Positive Breast Cancer
HER-2 positive
HER2 Positive Breast Cancer
ASLAN001
Sensitive: C2 – Inclusion Criteria
ASLAN001
Sensitive
:
C2
ASLAN001
Sensitive: C2 – Inclusion Criteria
ASLAN001
Sensitive
:
C2
EGFR overexpression
Gastric Cancer
EGFR overexpression
Gastric Cancer
ASLAN001
Sensitive: C3 – Early Trials
ASLAN001
Sensitive
:
C3
ASLAN001
Sensitive: C3 – Early Trials
ASLAN001
Sensitive
:
C3
EGFR expression + HER-2 expression
Gastric Cancer
EGFR expression + HER-2 expression
Gastric Cancer
ASLAN001
Sensitive: C3 – Early Trials
ASLAN001
Sensitive
:
C3
ASLAN001
Sensitive: C3 – Early Trials
ASLAN001
Sensitive
:
C3
EGFR overexpression + HER-2 overexpression
Cholangiocarcinoma
EGFR overexpression + HER-2 overexpression
Cholangiocarcinoma
ASLAN001
Sensitive: D – Preclinical
ASLAN001
Sensitive
:
D
ASLAN001
Sensitive: D – Preclinical
ASLAN001
Sensitive
:
D
EGFR overexpression + HER-2 overexpression
Cholangiocarcinoma
EGFR overexpression + HER-2 overexpression
Cholangiocarcinoma
AN2025 + ASLAN001
Sensitive: D – Preclinical
AN2025 + ASLAN001
Sensitive
:
D
AN2025 + ASLAN001
Sensitive: D – Preclinical
AN2025 + ASLAN001
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.